INSIGHTS ON DRUG DEVELOPMENT
-
N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy Retrofit
Discover a company that tripled productivity and cut costs by optimizing its seed train process to achieve major gains without infrastructure expansion.
-
Overcoming Challenges In Ophthalmic Formulations
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
Unlocking The Future: Exploring Cutting-Edge Cell And Gene Therapies
Explore the transformative potential of cutting-edge cell and gene therapies, focusing on CAR-T cell therapy, CRISPR-Cas9 gene editing, and other advanced approaches.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Recapitulating Inflammation: How To Use the Colon Intestine-Chip To Study Complex Mechanisms Of IBD4/9/2024
To address the challenges associated with conventional drug development models, a Colon Intestine-Chip has been developed to recapitulate the biology that drives inflammatory bowel disease.
-
Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability5/16/2024
A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.
-
Five Practical Considerations To Move From Concept To Clinic12/17/2025
Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
-
Designing The Human Emulation System4/9/2024
Examine how the Human Emulation System merges cutting-edge Organ-on-a-Chip technology with user-friendly design, paving the way for seamless experimentation and deeper insights into human biology.
-
A More Human-Relevant Model To Advance AAV-Based Gene Therapies3/8/2024
Learn about a liver-chip that offers a more human-relevant way of testing viral vectors compared to conventional models and why it is a promising tool for advancing AAV gene therapy.
DRUG DEVELOPMENT SOLUTIONS
-
The Intabio ZT system couples icIEF separation and UV detection with high resolution mass spectrometry on the ZenoTOF 7600 system.
-
Explore a range of devices for free fraction analyses and determination of plasma protein binding that make sample preparation easier and faster, with complete phospholipid removal and proven reproducibility.
-
Downstream process intensification offers major gains, but only with the right strategy. Learn how chromatography selection and expert input can help align purification workflows with production goals.
-
Re-engineer your drug's path into clinical development and accelerate time to Proof-of-Concept. Real-time data guides rapid formulation iterations, minimizing drug substance use and lowering program risk.
-
Biocatalysis enables cost efficient and environmentally friendly manufacturing through enzymatic synthesis and provides pure -regio, chemo- and enantioselective compounds when compared to traditional chemical synthesis.